Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Completed

Looking for future studies?

Key information

Conditions

Progressive Multifocal Leukoencephalopathy Brain Diseases Central Nervous System Diseases Central Nervous System Infections Central Nervous System Viral Diseases DNA Virus Infections Demyelinating Diseases Encephalitis Encephalitis, Viral Infections Infectious Encephalitis Leukoencephalopathies Leukoencephalopathy, Progressive Multifocal Nervous System Diseases Neuroinflammatory Diseases Polyomavirus Infections Slow Virus Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

HIV infected patients
Diagnosed with progressive multifocal leukoencephalopathy
Minimal follow-up of one year OR patient deceased less than one year after diagnosis

Exclusion criteria

Loss of follow-up within 12 months after diagnosis

Treatment and study plan

Primary outcomes

Rankin score

Time frame: 12 months after diagnosis of leukoencephalopathy

Sponsors and collaborators

Lead sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Network

Registry information

Acronym: LEMPMAR

Important dates

Study start: 2006
Primary completion: 2015
First posted: Sep 9, 2016
Registry last updated: Sep 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed